BIIB080 is an antisense oligonucleotide therapy designed to target microtubule-associated protein tau mRNA and reduce the production of tau.
Amidst the recent job cuts across federal health agencies, the FDA lead in tobacco regulation has been placed on leave.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback